Keros Therapeutics (KROS) EBITDA (2019 - 2025)
Keros Therapeutics (KROS) recorded EBITDA of -$28.87 million in Q4 2025, compared with -$52.92 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) EBITDA (2019 - 2025) Analysis & Trends
For FY2025, Keros Therapeutics reported EBITDA of $69.08 million.
- Across earlier years, EBITDA came in at -$209.6 million in FY2024, -$169.13 million in FY2023, -$114.12 million in FY2022 and -$56 million in FY2021.
- Quarterly EBITDA has ranged from -$58.34 million in Q3 2024 to $152.38 million in Q1 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$14.99 million (Q3 2025), -$39.45 million (Q2 2025) and $152.38 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.91 Bn | 1,101.50 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.07 Bn | 533.59 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 505.92 Bn | 479.03 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.25 Bn | 262.24 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.76 Bn | 235.45 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.19 Bn | 191.59 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.37 Bn | 117.02 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Keros Therapeutics | 224.34 Mn | -1.70 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -28.87 Mn |
| Sep 30, 2025 | -14.99 Mn |
| Jun 30, 2025 | -39.45 Mn |
| Mar 31, 2025 | 152.38 Mn |
| Dec 31, 2024 | -52.92 Mn |
| Sep 30, 2024 | -58.34 Mn |
| Jun 30, 2024 | -50.13 Mn |
| Mar 31, 2024 | -48.21 Mn |
| Dec 31, 2023 | -46.21 Mn |
| Sep 30, 2023 | -43.07 Mn |
| Jun 30, 2023 | -41.15 Mn |
| Mar 31, 2023 | -38.70 Mn |
| Dec 31, 2022 | -31.83 Mn |
| Sep 30, 2022 | -27.85 Mn |
| Jun 30, 2022 | -30.42 Mn |
| Mar 31, 2022 | -24.01 Mn |
| Dec 31, 2021 | -4.76 Mn |
| Sep 30, 2021 | -20.09 Mn |
| Jun 30, 2021 | -15.45 Mn |
| Mar 31, 2021 | -15.69 Mn |
API Access
Keros Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();